Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma
- 29 February 2000
- journal article
- Published by Elsevier in International Journal of Oral & Maxillofacial Surgery
- Vol. 29 (1) , 36-41
- https://doi.org/10.1016/s0901-5027(00)80122-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Clinical applications of molecular biology in radiation oncologySeminars in Radiation Oncology, 1996
- Sequential p53 mutation analysis of pre‐invasive and invasive head and neck squamous carcinomaInternational Journal of Cancer, 1995
- Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: Results of RTOG 91-08International Journal of Radiation Oncology*Biology*Physics, 1994
- p53, guardian of the genomeNature, 1992
- Prognostic importance of cellular dna content in head‐and‐neck squamous‐cell cancers. A comparison of retrospective and prospective seriesInternational Journal of Cancer, 1991
- Cellular dna content parameters in untreated and recurrent squamous cell cancers of the head and neckCytometry, 1989
- Multivariate survival analysis using Cox's regression modelHepatology, 1987
- Part I. DNA Flow Cytometry as a Prognostic Indicator in Head and Neck CancerOtolaryngology -- Head and Neck Surgery, 1987
- DNA measurement – An objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavityBritish Journal of Cancer, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981